K241427

Substantially Equivalent

Access Syphilis

Applicant: Beckman Coulter, Inc.
Product code: LIP
Advisory panel: Microbiology
Date received: 2024-05-20
Decision date: 2024-09-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chaska, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.